Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Eagle Pharmaceuticals Inc (EGRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Eagle Pharm's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
44.83 -1.28    -2.78%
15:59:59 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US2697961082 
CUSIP:  269796108
  • Volume: 169,505
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 44.50 - 47.41
Eagle Pharm 44.83 -1.28 -2.78%
Start Date Username Call Open Rate End Date Chg. %
Mar 29, 2022 Andrea Masciadri   50.00 Apr 22, 2022 @ 48.41 -3.18%
Mar 28, 2022 Jo He   51.92 Apr 04, 2022 @ 50.34 -3.04%
Dec 15, 2021 Екатерина Дубровина   45.30 Jan 07, 2022 @ 50.63 -11.77%
Aug 20, 2021 Eric Zhang   49.20 Sep 10, 2021 @ 51.70 -5.08%
Jul 14, 2021 Коробинцев Леонид   48.58 Aug 06, 2021 @ 45.77 -5.78%
May 07, 2021 виктор дзивицкий   40.67 May 10, 2021 @ 40.41 +0.64%
Apr 26, 2021 Robbert Kuipers   41.78 May 03, 2021 @ 42.00 +0.53%
Jan 22, 2021 iyri petrov   47.01 Feb 12, 2021 @ 46.35 -1.40%
Nov 10, 2020 waleed ba   49.34 Nov 11, 2020 @ 49.85 -1.03%
Nov 04, 2020 waleed ba   52.30 Nov 09, 2020 @ 48.91 -6.48%
Nov 02, 2020 waleed ba   51.12 Nov 04, 2020 @ 52.30 -2.31%
Sep 16, 2020 mike kerckaert   38.89 Oct 09, 2020 @ 46.35 +19.18%
Aug 10, 2020 Aleksandr Timoshin   39.93 Sep 04, 2020 @ 37.25 +6.71%
Jul 31, 2020 Sergey Multakh   46.56 Aug 21, 2020 @ 41.23 -11.45%
May 08, 2020 Nick Nick   54.15 May 29, 2020 @ 51.26 -5.34%
May 01, 2020 Karthikeyan Subramani   51.39 May 01, 2020 @ 51.39 0.00%
Jan 08, 2020 Joshua Morales   56.40 Jan 31, 2020 @ 53.82 -4.57%
Oct 30, 2019 Eric Lee   63.48 Nov 07, 2019 @ 60.14 -5.26%
Sep 28, 2018 rambabu goru   69.06 Oct 28, 2018 @ 73.24 +6.05%
Sep 26, 2018 alfa beta gamma   67.98 Oct 26, 2018 @ 73.24 +7.74%
Feb 23, 2018 John Odonoghue   65.02 Mar 25, 2018 @ 52.23 +19.67%
Feb 16, 2018 Episcopolian1   65.29 Mar 18, 2018 @ 53.90 -17.45%
Jan 12, 2018 Episcopolian1   63.69 Feb 11, 2018 @ 56.81 -10.80%
Dec 04, 2017 Marco Schiavi   61.44 Jan 03, 2018 @ 58.69 -4.48%
Oct 18, 2017 Роман Тихоновец   49.25 Nov 17, 2017 @ 57.40 +16.55%
May 16, 2017 Episcopolian1   80.94 Jun 15, 2017 @ 73.18 +9.59%
Apr 06, 2015 davide garulli   46.55 May 06, 2015 @ 56.84 -22.11%
Mar 02, 2015 davide garulli   37.27 Apr 01, 2015 @ 46.47 -24.68%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EGRX Comments

Write your thoughts about Eagle Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Well Rounded
Well Rounded Apr 11, 2022 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock hasn't acsended above $90, since Hershey Holding bit a percentage of their company...Just saying!! 🤔
Zoran Labus
Zoran Labus Mar 25, 2021 11:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
Episcopolian OptionTrader
Episcopolian1 Feb 16, 2018 11:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Two upcoming catalysts: 1) RBC Capital market healthcare on 2/21 and earnings on 2/26 (morning). One of these two days, we may get updates on pending court case against $LLY regarding PEMFEXY.. Floor chatter is that $EGRX will prevail...
Episcopolian OptionTrader
Episcopolian1 Jan 12, 2018 11:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Rumor is swirling on the trading floor that $EGRX will win the law-suit against $LLY!
Episcopolian OptionTrader
Episcopolian1 May 16, 2017 9:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Erin Consulting downgrades it to SELL with PT $70
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email